$1.25
0.05 (-3.85%)
Last updated: Apr 16, 2026 04:52
Fundamentals Overview
Celularity Inc. is near the low of its 52-week range with low valuation, trending downward today.
Valuation low
Risk (Beta)
0.71 — lower vol
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Pressures (Sell):
Sentiment weakening (6 downgrades) · 3M vs S&P 500: -6%
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: C. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 6, Equal Weight: 3, Hold: 4, Outperform: 1, Perform: 2, Underweight: 2.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $-168.39; current price is $1.25. That’s a -13570.9% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | N/A |
| PEG (TTM) | N/A |
| P/B (TTM) | N/A |
| P/S (TTM) | 0.74 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 0.16 |
| Quick Ratio (TTM) | 0.12 |
| Cash Ratio (TTM) | 0 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | -1.99% |
| Gross margin (TTM) | 55.25% |
| Operating margin (TTM) | -1.2% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for CELU.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| WBB Securities | upgrade | Hold | Buy | 2025-09-09 |
| Morgan Stanley | downgrade | Equal Weight | Underweight | 2023-01-30 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2023-01-30 |
| Morgan Stanley | downgrade | Equal Weight | Underweight | 2023-01-29 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2023-01-29 |
| Oppenheimer | downgrade | Outperform | Perform | 2022-12-22 |
| Oppenheimer | downgrade | Outperform | Perform | 2022-12-21 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2022-09-12 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2022-09-11 |
| Alliance Global Partners | maintain | Buy | Buy | 2022-08-25 |
| Truist Securities | maintain | Hold | Hold | 2022-08-23 |
| Truist Securities | maintain | Hold | Hold | 2022-08-22 |
| HC Wainwright & Co. | maintain | Buy | Buy | 2022-06-22 |
| Truist Securities | downgrade | Buy | Hold | 2022-04-06 |
| Truist Securities | downgrade | Buy | Hold | 2022-04-05 |
| Oppenheimer | maintain | Outperform | Outperform | 2022-01-28 |
| Morgan Stanley | maintain | Equal Weight | Equal Weight | 2021-11-24 |
| Truist Securities | maintain | Buy | Buy | 2021-10-19 |